Article
Licensed
Unlicensed Requires Authentication

Published/Copyright: May 17, 2007

- Evidence in action/diabetes S13

- Standardisation in laboratory medicine: the way forward S16

- Recent developments in parathyroid hormone S19

- Epigenetics in complex disease S21

- Haemoglobinopathies S24

- Pharmacogenetics and pharmacogenomics S27

- Frontiers in technology and methods - I S30

- Advances in laboratory automation and information technology S32

- Obesity S35

- Frontiers in technology and methods - II S37

- Diseases of ageing; biomarkers in neurodegenerative disease S39

- Late breaking news S41

- Iron metabolism S43

- Mass spectrometry in the clinical laboratory S46

- Bleeding disorders S48

- Metabolic disease S51

- Drugs of abuse; therapeutic drug monitoring S54

- Scientific communications S56

- Contribution of laboratory medicine in kidney disease S57

- Osteoporosis and calcium homeostasis S60

- Your future in patient care - II: laboratory response to changing regulatory environment S62

- Cardiac markers and vascular disease S65

- Oncology - tumour markers S68

- Clinical and diagnostic immunology S70

- Your future in patient care - I: laboratory response to changing technology S72

Published Online: 2007-05-17
Published in Print: 2007-06-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Opening Lecture Abstracts
  2. Plenary Lecture Abstracts
  3. Symposium Abstracts
  4. Industrial Sponsored Workshop Abstracts
  5. Poster Abstracts
  6. Adrenal
  7. Adrenal
  8. Fertility
  9. Fertility
  10. Genetics
  11. Genetics
  12. Haematology
  13. Haematology
  14. Haemostasis
  15. Haemostasis
  16. Infectious diseases
  17. Infectious diseases
  18. Iron metabolism/haemochromatosis
  19. Iron metabolism/haemochromatosis
  20. Metabolic syndrome(s)
  21. Metabolic syndrome(s)
  22. Neonatology
  23. Neonatology
  24. Pharmacogenetics/pharmacogenomics
  25. Pharmacogenetics/pharmacogenomics
  26. Point of care testing
  27. Point of care testing
  28. Quality assessment
  29. Quality assessment
  30. Reproductive endocrinology
  31. Reproductive endocrinology
  32. Technology, instrumentation and methods
  33. Technology, instrumentation and methods
  34. Ageing
  35. Ageing
  36. Bone disease and vitamin D
  37. Bone disease and vitamin D
  38. Cardiovascular disease: coronary artery disease/ischaemic damage
  39. Cardiovascular disease: coronary artery disease/ischaemic damage
  40. Diabetes
  41. Diabetes
  42. Information technology
  43. Information technology
  44. Kidney disease
  45. Kidney disease
  46. Liver and gastrointestinal disease
  47. Liver and gastrointestinal disease
  48. Miscellaneous
  49. Miscellaneous
  50. Neurodegenerative diseases
  51. Neurodegenerative diseases
  52. Nutrition
  53. Nutrition
  54. Thyroid
  55. Thyroid
  56. Allergy
  57. Allergy
  58. Autoimmune diseases
  59. Autoimmune diseases
  60. Blood banking and haemovigilance
  61. Blood banking and haemovigilance
  62. Cancer/tumour markers
  63. Cancer/tumour markers
  64. Cardiovascular disease: heart failure/hypertension
  65. Cardiovascular disease: heart failure/hypertension
  66. Clinical relevance of laboratory testing
  67. Clinical relevance of laboratory testing
  68. Critical care
  69. Critical care
  70. Immunology/antibody technology
  71. Immunology/antibody technology
  72. Inherited and acquired metabolic disease
  73. Inherited and acquired metabolic disease
  74. Lipids and lipoproteins
  75. Lipids and lipoproteins
  76. Molecular diagnostics
  77. Molecular diagnostics
  78. Paediatric clinical chemistry
  79. Paediatric clinical chemistry
  80. Proteins and proteomics/chips and mass spectrometry
  81. Proteins and proteomics/chips and mass spectrometry
  82. Traceability and standardisation
  83. Traceability and standardisation
  84. Author Index
Downloaded on 2.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.202/html
Scroll to top button